Next FDA Commissioner Must Promote Competition, Transparency And Value In The Pharmaceutical Marketplace For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today ahead of a U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) executive session to consider the nomination of Dr. Robert […]
Fourth Major Round Of Pandemic Price Hikes Highlight Urgency for Policymakers to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today reacting to Big Pharma increasing prices on 434 brand name drugs in just the first few days of 2022 […]
U.S. House Oversight & Reform Committee Report Finds Big Pharma’s Pricing Practices Are “Unsustainable, Unjustifiable and Unfair” For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to a new report from the U.S. House Committee on Oversight and Reform […]
Congress Must Capitalize on Historic Opportunity to Lower Drug Prices, Reject Pharma-Backed Policies That Would Hike Health Care Premiums For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to the U.S. House passage of drug pricing provisions contained in the […]
Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical Benefit Will Cost Medicare Part B Outpatients $21.60 More Per Month For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on news that Medicare Part B premiums for outpatient beneficiaries will increase by […]
Congress Should Reject Pharma-backed Proposals That Would Hike Health Care Premiums, Advance Solutions to Deliver Real Rx Relief for the American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday reacting to the release of a drug pricing compromise package to be included […]
Framework Fails to Hold Big Pharma Accountable and Lower Drug Prices for the American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to the release of a framework from President Biden for the Build Back Better Act. “This framework fails […]
U.S. Food & Drug Administration Approval of Cyltezo Marks Second Interchangeable Biosimilar Approved by Agency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to the Food and Drug Administration’s (FDA) decision Monday to approve interchangeable biosimilar Cyltezo, as an alternative to […]
Committee Mark Up Targets Brand Name Drug Companies’ Anti-Competitive Tactics That Undermine More Affordable Alternatives For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in advance of a U.S. House of Representatives Committee on the Judiciary mark up of two bills that […]
Americans Blame Big Pharma for Out-of-Control Drug Prices, Reject Bogus Innovation Rhetoric And Say Lack of Action in Congress Would Impact Vote in Next Election For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey conducted by Morning Consult Tuesday. “The […]